This course provides a comprehensive understanding of Waiver & Cure Period Monitoring within the framework of Credit Monitoring & Portfolio Surveillance. Learners will explore how financial institutions monitor agreed waiver conditions, track cure period obligations, and manage covenant remediation timelines as part of structured credit risk oversight and compliance surveillance activities.

The course explains the scope, intent, and governance significance of Waiver & Cure Period Monitoring in credit environments that require structured assessment, boundary definition, independent review, and documented decision-making. Participants will learn how waiver and cure period monitoring supports proactive portfolio risk management, strengthens compliance governance, and improves the timely identification of unresolved covenant and exposure concerns.

Key concepts covered include early warning signal identification, risk trend analysis, proactive portfolio risk management, and assessment scope evaluation. Each component is treated as a distinct assessment dimension requiring independent validation, evidence-based analysis, and documented rationale before any monitoring recommendation, waiver-related action, or credit decision is finalized.

The module also distinguishes Waiver & Cure Period Monitoring from broader early warning detection systems. While early warning detection systems provide strategic monitoring across multiple portfolio risk indicators and surveillance frameworks, Waiver & Cure Period Monitoring specifically addresses the structured tracking of covenant breaches, waiver conditions, remediation timelines, cure period compliance, and escalation response procedures. Learners will understand how these functions operate under separate governance structures, ownership responsibilities, evidence standards, and approval authorities.

Special emphasis is placed on Covenant Monitoring & Compliance Surveillance activities, where credit managers validate team-level waiver and cure period analysis, approve case recommendations, and oversee segment-level exposure management within Credit Monitoring & Portfolio Surveillance functions. The course demonstrates how waiver status and cure period outcomes influence escalation scope, surveillance prioritization, portfolio review intensity, and credit committee focus.

By the end of this course, learners will be able to monitor waiver conditions, assess cure period compliance, identify unresolved covenant risks, and contribute effectively to structured covenant surveillance, escalation governance, and portfolio risk management within modern credit monitoring environments.